This comment by the Chairman should give us shareholders plenty of optimism moving forward:
“ResMed’s strong third-quarter fiscal year 2024 results reflect robust patient and customer demand for our products and software solutions, leading to double-digit mask and accessories revenue growth along with ongoing operational efficiencies to drive margin improvement and increased profitability, resulting in double-digit growth in both operating profit and earnings per share,” said Mick Farrel
This comment by the Chairman should give us shareholders plenty...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.69 |
Change
0.080(0.25%) |
Mkt cap ! $20.85B | |||
| Open | High | Low | Value | Volume |
| $32.70 | $32.87 | $32.46 | $56.99M | 1.747M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8321 | $32.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $32.70 | 3029 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$32.70 |
Change
0.080 ( 0.30 %) |
||||
| Open | High | Low | Volume | ||
| $32.72 | $32.86 | $32.46 | 200107 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| RMD (ASX) Chart |